https://ir.lenz-tx.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_8635510463fa1e52d68f761be7047ea9/lenztx/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.lenz-tx.com/news-events/press-releases/detail/52/lenz-therapeutics-reports-fourth-quarter-and-full-year-2025-financial-results-and-recent-corporate-highlights Tue, 24 Mar 26 08:00:00 -0400 https://ir.lenz-tx.com/news-events/press-releases/detail/52/lenz-therapeutics-reports-fourth-quarter-and-full-year-2025-financial-results-and-recent-corporate-highlights https://ir.lenz-tx.com/news-events/press-releases/detail/51/lenz-therapeutics-to-report-fourth-quarter-and-full-year-2025-financial-results-and-recent-corporate-highlights-on-march-24-2026 Tue, 17 Mar 26 08:00:00 -0400 https://ir.lenz-tx.com/news-events/press-releases/detail/51/lenz-therapeutics-to-report-fourth-quarter-and-full-year-2025-financial-results-and-recent-corporate-highlights-on-march-24-2026 https://ir.lenz-tx.com/news-events/press-releases/detail/50/lenz-therapeutics-announces-submission-of-marketing-authorization-application-to-european-medicines-agency-for-vizz-for-the-treatment-of-presbyopia Tue, 10 Mar 26 08:00:00 -0400 https://ir.lenz-tx.com/news-events/press-releases/detail/50/lenz-therapeutics-announces-submission-of-marketing-authorization-application-to-european-medicines-agency-for-vizz-for-the-treatment-of-presbyopia https://ir.lenz-tx.com/news-events/press-releases/detail/49/lenz-therapeutics-to-present-at-upcoming-investor-conferences Mon, 23 Feb 26 08:00:00 -0500 https://ir.lenz-tx.com/news-events/press-releases/detail/49/lenz-therapeutics-to-present-at-upcoming-investor-conferences https://ir.lenz-tx.com/news-events/press-releases/detail/48/lenz-therapeutics-and-sarah-jessica-parker-announce-the-launch-of-make-it-vizzable-the-vizz-consumer-campaign Wed, 14 Jan 26 08:30:00 -0500 https://ir.lenz-tx.com/news-events/press-releases/detail/48/lenz-therapeutics-and-sarah-jessica-parker-announce-the-launch-of-make-it-vizzable-the-vizz-consumer-campaign https://ir.lenz-tx.com/news-events/press-releases/detail/47/lenz-therapeutics-reports-fourth-quarter-2025-preliminary-unaudited-financial-results-and-recent-corporate-updates Wed, 07 Jan 26 17:08:00 -0500 https://ir.lenz-tx.com/news-events/press-releases/detail/47/lenz-therapeutics-reports-fourth-quarter-2025-preliminary-unaudited-financial-results-and-recent-corporate-updates https://ir.lenz-tx.com/news-events/press-releases/detail/46/lenz-therapeutics-and-lunatus-announce-exclusive-commercialization-partnership-for-vizzin-the-middle-east Mon, 05 Jan 26 08:00:00 -0500 https://ir.lenz-tx.com/news-events/press-releases/detail/46/lenz-therapeutics-and-lunatus-announce-exclusive-commercialization-partnership-for-vizzin-the-middle-east https://ir.lenz-tx.com/news-events/press-releases/detail/45/lenz-therapeutics-announces-mfds-submission-of-new-drug-application-for-lnz100-vizz-in-south-korea-for-the-treatment-of-presbyopia Mon, 01 Dec 25 08:30:00 -0500 https://ir.lenz-tx.com/news-events/press-releases/detail/45/lenz-therapeutics-announces-mfds-submission-of-new-drug-application-for-lnz100-vizz-in-south-korea-for-the-treatment-of-presbyopia https://ir.lenz-tx.com/news-events/press-releases/detail/44/lenz-therapeutics-to-present-at-upcoming-investor-conferences Tue, 25 Nov 25 16:05:00 -0500 https://ir.lenz-tx.com/news-events/press-releases/detail/44/lenz-therapeutics-to-present-at-upcoming-investor-conferences https://ir.lenz-tx.com/news-events/press-releases/detail/43/lenz-therapeutics-reports-third-quarter-2025-financial-results-and-recent-corporate-highlights Wed, 05 Nov 25 08:00:00 -0500 https://ir.lenz-tx.com/news-events/press-releases/detail/43/lenz-therapeutics-reports-third-quarter-2025-financial-results-and-recent-corporate-highlights